Linkedin-in Facebook-f
Our Portfolio Companies
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
    • Courses
  • Contact Us
Menu
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
    • Courses
  • Contact Us
Briefcase Loading...

No. 6745

Add to Briefcase

Repurposing Approved Drugs for New Indications

CategoryLife Sciences and Biotechnology
KeywordsDrug Repurposing, Computational biology, Personalized medicine

Our innovation
The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery and repositioning. Using advanced comparative genomic and data integration, our lab has been developing a state-of-the-art AI algorithm which maps drug and food supplements that are useful in treating diseases and improving health conditions. To create this algorithm, we have been integrating and analyzing massive amounts of genomic data from 1,600 genomes, 14,000 compounds, 20,000 human genes, and a comprehensive database of phenotypic data.

Opportunity
We now propose harnessing our unique approach to discover drugs that fight against various pathogens and disease states. We have already demonstrated that applying our unique AI algorithm has yielded a preliminary list of possible drugs with the promise of affecting various medical conditions.

Lead Researcher

Dr. Yuval Tabach

Developmental Biology and Cancer Research

Business Development Person

Ariela Markel VP, BD, Healthcare Contact

Category

  • Medical Devices & Digital Health, Pharmaceuticals
ADDRESS

Hi-Tech Park, Edmond J. Safra
Campus, Bungalow 2.6
Givat-Ram, Jerusalem
P.O. Box 39135
91390 Israel

CONTACT US
  • Phone: +972-2-658-6688
  • Fax: +972-2-658-6689
  • Email: [email protected]
FOLLOW US
Twitter Linkedin-in Facebook-f Youtube
COPYRIGHT
Twitter Linkedin-in Facebook-f Youtube
  • About Us
    • About Us
    • Staff and Board of Directors
  • Industry & Investors
    • Partnership Models
    • Venture Funds
  • Success Stories
  • Media Center
    • News
    • Podcasts
    • Press Releases
  • Faculty & Researchers
    • Courses
  • Contact Us
Search Our Technologies
Find a Research Expert
Our Portfolio Companies
Briefcase Loading...